Patents by Inventor Jou Akitomi

Jou Akitomi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11643660
    Abstract: The present invention provides a novel nucleoside derivative or a salt thereof, a polynucleotide synthesis reagent, a method for producing a polynucleotide, a polynucleotide, and a method for producing a binding nucleic acid molecule. The nucleoside derivative or a salt thereof of the present invention is represented by the following chemical formula (1). In the chemical formula (1), Su is an atomic group having a sugar skeleton at a nucleoside residue or an atomic group having a sugar phosphate skeleton at a nucleotide residue, and may or may not have a protecting group, L1 and L2 are each independently a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms, X1 is an imino group (—NR1—), an ether group (—O—), or a thioether group (—S—), and R1 is a hydrogen atom or a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: May 9, 2023
    Assignees: NEC SOLUTION INNOVATORS, LTD., NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
    Inventors: Hirotaka Minagawa, Katsunori Horii, Jou Akitomi, Naoto Kaneko, Iwao Waga, Masayasu Kuwahara
  • Patent number: 11373507
    Abstract: The continual engagement support device 600 includes: the performance data storage means 601 that stores performance data including time data indicating the time of performance and sensor data of the time of performance or the surrounding time obtained from the sensors mounted on the portable terminal when the target action is performed via the portable terminal possessed by the target user; the timing detection means 602 that detects the performance timing, which is the timing at which the target user is likely to perform the target action during the predetermined cycle, on the basis of the performance data; and the notification means 603 provides a notification to prompt the performance of the target action at the detected performance timing when the target action is not performed for a predetermined period of time or longer.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: June 28, 2022
    Assignee: NEC Solution Innovators, Ltd.
    Inventors: Ikuo Kajiyama, Jou Akitomi, Miho Ishii
  • Publication number: 20220148696
    Abstract: An apparatus (10) for lifestyle habit recommendation, comprising at least one processor configured to: acquire execution information executed for each item serving as an indicator of a lifestyle habit and a vitality level of a sample user in association with a date; set a scheduled date on which a vitality level of a target user is required to be a predetermined value; set a given period up to the scheduled date as an output period of recommended lifestyle habit information; acquire a date on which the associated vitality level of the sample user is the predetermined value, and determines the execution information corresponding to the number of days of the output period up to the date as the recommended information in the output period; and output the recommended information to the target user.
    Type: Application
    Filed: March 12, 2020
    Publication date: May 12, 2022
    Applicant: NEC Solution Innovators, Ltd.
    Inventors: Jou AKITOMI, Mineko YAMAYUCHI
  • Patent number: 11236342
    Abstract: The present invention provides a novel molecule that can be used for detection of sIgA. The sIgA-binding nucleic acid molecule of the present invention is characterized in that it binds to secretory immunoglobulin A (sIgA) with a dissociation constant of 37.7 nM or less, and preferably includes a polynucleotide consisting of any of base sequences of SEQ ID NOs: 1 to 12 or a partial sequence thereof, for example. According to the sIgA-binding nucleic acid molecule of the present invention, it is possible to detect sIgA in saliva.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: February 1, 2022
    Assignees: NEC Solution Innovators, Ltd., NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
    Inventors: Hirotaka Minagawa, Katsunori Horii, Jou Akitomi, Naoto Kaneko, Iwao Waga, Masayasu Kuwahara
  • Publication number: 20210304034
    Abstract: A lifestyle habit recommendation apparatus 10 of the present invention, includes: an execution information acquisition unit 11; a vitality level calculation unit 12; a recommended information determination unit 13; and an output unit 14, wherein the execution information acquisition unit 11 acquires execution information executed for each item serving as an indicator of a lifestyle habit and a vitality level of a user in association with a date, the vitality level calculation unit 12 calculates, based on the execution information and the vitality level of the user in a predictive input period, the vitality level of the user after a predetermined number of days from the predictive input period, the recommended information determination unit 13 calculates recommended execution information up to the predetermined number of days so that the calculated vitality level can be raised, and the output unit 14 outputs the recommended execution information to the user.
    Type: Application
    Filed: March 24, 2021
    Publication date: September 30, 2021
    Applicant: NEC Solution Innovators, Ltd.
    Inventor: Jou AKITOMI
  • Publication number: 20210201649
    Abstract: The continual engagement support device 600 includes: the performance data storage means 601 that stores performance data including time data indicating the time of performance and sensor data of the time of performance or the surrounding time obtained from the sensors mounted on the portable terminal when the target action is performed via the portable terminal possessed by the target user; the timing detection means 602 that detects the performance timing, which is the timing at which the target user is likely to perform the target action during the predetermined cycle, on the basis of the performance data; and the notification means 603 provides a notification to prompt the performance of the target action at the detected performance timing when the target action is not performed for a predetermined period of time or longer.
    Type: Application
    Filed: June 26, 2019
    Publication date: July 1, 2021
    Applicant: NEC Solution Innovators, Ltd.
    Inventors: Ikuo KAJIYAMA, Jou AKITOMI, Miho ISHII
  • Publication number: 20210187499
    Abstract: A target analysis kit includes: a sample holder including: a reagent chamber containing a first reagent; a sample holding portion; and a liquid transfer portion; and an analysis container including: a first chamber containing a second reagent; and a second chamber with a labeling substance contained in the first or second reagent to be detected. A combination of the first and second reagents is any of the combinations (1) to (3) and (4): (1) first reagent is the immobilized second binding substance and second reagent is the labeled first binding substance; (2) first reagent is the labeled first binding substance and second reagent is the immobilized second binding substance; (3) first reagent is the immobilized first binding substance and second reagent is the labeled second binding substance; and (4) first reagent is the labeled second binding substance and second reagent is the immobilized first binding substance.
    Type: Application
    Filed: March 23, 2017
    Publication date: June 24, 2021
    Applicant: NEC Solution Innovators, Ltd.
    Inventors: Yoshihito YOSHIDA, Katsunori HORII, Iwao WAGA, Jou AKITOMI, Naoto KANEKO
  • Patent number: 10934548
    Abstract: The present invention provides a novel nucleic acid molecule that can be used for detection of a wheat allergen. The wheat allergen-binding nucleic acid according to the present invention is characterized in that it binds to a wheat allergen with a dissociation constant of 20 nM or less, and preferably includes a polynucleotide consisting of either of base sequences of SEQ ID NOs: 1 and 2, for example.
    Type: Grant
    Filed: November 16, 2015
    Date of Patent: March 2, 2021
    Assignee: NEC Solution Innovators, Ltd.
    Inventors: Tomoko Shiratori, Naoto Kaneko, Ikuo Shiratori, Katsunori Horii, Hirotaka Minagawa, Jou Akitomi, Yoshihito Yoshida, Iwao Waga
  • Patent number: 10781230
    Abstract: The present invention provides a novel nucleoside derivative or a salt thereof, a polynucleotide synthesis reagent, a method for producing a polynucleotide, a polynucleotide, and a method for producing a binding nucleic acid molecule. The nucleoside derivative or a salt thereof of the present invention is represented by the following chemical formula (1): where in the chemical formula (1), Su is an atomic group having a sugar skeleton at a nucleoside residue or an atomic group having a sugar phosphate skeleton at a nucleotide residue, and may or may not have a protecting group, L1 and L2 are each independently a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms, X1 and X2 are each independently an imino group (—NR1—), an ether group (—O—), or a thioether group (—S—), and the R1 is a hydrogen atom or a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: September 22, 2020
    Assignees: NEC Solution Innovators, Ltd., NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
    Inventors: Hirotaka Minagawa, Katsunori Horii, Jou Akitomi, Naoto Kaneko, Iwao Waga, Masayasu Kuwahara
  • Publication number: 20200294651
    Abstract: A sleep improvement assistance system 600 of the present invention includes: an information providing unit 601 that uses an automatic discrimination model that automatically determines and outputs, when user information that is information regarding sleep of a target user is inputted, an output suitable for the target user from a predetermined output set in accordance with a phase of a sleep improvement program of the target user, to provide information to the target user; a result data storage unit 602 that stores result data including at least user information and information regarding executed information provision, for a past user who has finished a sleep improvement program; and a criterion correction unit 603 that compares, in using an automatic determination model, user information of the target user with user information included in the result data, and corrects a determination criterion for an output of the automatic discrimination model.
    Type: Application
    Filed: September 5, 2018
    Publication date: September 17, 2020
    Applicant: NEC Solution Innovators, Ltd.
    Inventor: Jou AKITOMI
  • Patent number: 10760084
    Abstract: The present invention provides a novel nucleic acid molecule that can be used for detection of ?-amylase. The ?-amylase-binding nucleic acid molecule of the present invention is characterized in that it binds to ?-amylase with a dissociation constant of 17 nM or less, and preferably includes a polynucleotide consisting of any of base sequences of SEQ ID NOs: 1 to 22, for example. According to the nucleic acid molecule of the present invention, it is possible to detect ?-amylase in saliva.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: September 1, 2020
    Assignees: NEC Solution Innovators, Ltd., Gunma University
    Inventors: Hirotaka Minagawa, Katsunori Horii, Jou Akitomi, Naoto Kaneko, Ikuo Shiratori, Iwao Waga, Masayasu Kuwahara
  • Publication number: 20200248181
    Abstract: The present invention provides a novel nucleic acid molecule that can be used for detection of a wheat allergen. The wheat allergen-binding nucleic acid according to the present invention is characterized in that it binds to a wheat allergen with a dissociation constant of 20 nM or less, and preferably includes a polynucleotide consisting of either of base sequences of SEQ ID NOs: 1 and 2, for example.
    Type: Application
    Filed: November 16, 2015
    Publication date: August 6, 2020
    Applicant: NEC Solution Innovators, Ltd.
    Inventors: Tomoko SHIRATORI, Naoto KANEKO, Ikuo SHIRATORI, Katsunori HORII, Hirotaka MINAGAWA, Jou AKITOMI, Yoshihito YOSHIDA, Iwao WAGA
  • Patent number: 10662216
    Abstract: The present invention provides a novel nucleoside derivative or a salt thereof, a polynucleotide synthesis reagent, a method for producing a polynucleotide, a polynucleotide, and a method for producing a binding nucleic acid molecule. The nucleoside derivative or a salt thereof of the present invention is represented by the following chemical formula (1): where in the chemical formula (1), Su is an atomic group having a sugar skeleton at a nucleoside residue or an atomic group having a sugar phosphate skeleton at a nucleotide residue, and may or may not have a protecting group, L1 and L2 are each independently a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms, X1 and X2 are each independently an imino group (—NR1—), an ether group (—O—), or a thioether group (—S—), and the R1 is a hydrogen atom or a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: May 26, 2020
    Assignees: NEC Solution Innovators, Ltd., NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
    Inventors: Hirotaka Minagawa, Katsunori Horii, Jou Akitomi, Naoto Kaneko, Iwao Waga, Masayasu Kuwahara
  • Patent number: 10618928
    Abstract: The present invention provides a novel nucleoside derivative or a salt thereof, a polynucleotide synthesis reagent, a method for producing a polynucleotide, a polynucleotide, and a method for producing a binding nucleic acid molecule. The nucleoside derivative or a salt thereof of the present invention is represented by the following chemical formula (1): where in the chemical formula (1), Su is an atomic group having a sugar skeleton at a nucleoside residue or an atomic group having a sugar phosphate skeleton at a nucleotide residue, and may or may not have a protecting group, L1 and L2 are each independently a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms, X1 and X2 are each independently an imino group (—NR1—), an ether group (—O—), or a thioether group (—S—), and the R1 is a hydrogen atom or a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: April 14, 2020
    Assignees: NEC Solution Innovators, Ltd., NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
    Inventors: Hirotaka Minagawa, Katsunori Horii, Jou Akitomi, Naoto Kaneko, Iwao Waga, Masayasu Kuwahara
  • Patent number: 10611791
    Abstract: The present invention provides a novel nucleoside derivative or a salt thereof, a polynucleotide synthesis reagent, a method for producing a polynucleotide, a polynucleotide, and a method for producing a binding nucleic acid molecule. The nucleoside derivative or a salt thereof of the present invention is represented by the following chemical formula (1): where in the chemical formula (1), Su is an atomic group having a sugar skeleton at a nucleoside residue or an atomic group having a sugar phosphate skeleton at a nucleotide residue, and may or may not have a protecting group, L1 and L2 are each independently a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms, X1 and X2 are each independently an imino group (—NR1—), an ether group (—O—), or a thioether group (—S—), and the R1 is a hydrogen atom or a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: April 7, 2020
    Assignees: NEC Solution Innovators, Ltd., NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
    Inventors: Hirotaka Minagawa, Katsunori Horii, Jou Akitomi, Naoto Kaneko, Iwao Waga, Masayasu Kuwahara
  • Publication number: 20190382765
    Abstract: The present invention provides a novel nucleoside derivative or a salt thereof, a polynucleotide synthesis reagent, a method for producing a polynucleotide, a polynucleotide, and a method for producing a binding nucleic acid molecule. The nucleoside derivative or a salt thereof of the present invention is represented by the following chemical formula (1). In the chemical formula (1), Su is an atomic group having a sugar skeleton at a nucleoside residue or an atomic group having a sugar phosphate skeleton at a nucleotide residue, and may or may not have a protecting group, L1 and L2 are each independently a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms, X1 is an imino group (—NR1—), an ether group (—O—), or a thioether group (—S—), and R1 is a hydrogen atom or a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms.
    Type: Application
    Filed: October 12, 2017
    Publication date: December 19, 2019
    Applicants: NEC Solution Innovators, Ltd., National University Corporation Gunma University
    Inventors: Hirotaka MINAGAWA, Katsunori HORII, Jou AKITOMI, Naoto KANEKO, Iwao WAGA, Masayasu KUWAHARA
  • Publication number: 20190248826
    Abstract: The present invention provides a novel nucleoside derivative or a salt thereof, a polynucleotide synthesis reagent, a method for producing a polynucleotide, a polynucleotide, and a method for producing a binding nucleic acid molecule. The nucleoside derivative or a salt thereof of the present invention is represented by the following chemical formula (1): where in the chemical formula (1), Su is an atomic group having a sugar skeleton at a nucleoside residue or an atomic group having a sugar phosphate skeleton at a nucleotide residue, and may or may not have a protecting group, L1 and L2 are each independently a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms, X1 and X2 are each independently an imino group (—NR1—), an ether group (—O—), or a thioether group (—S—), and the R1 is a hydrogen atom or a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms.
    Type: Application
    Filed: September 14, 2017
    Publication date: August 15, 2019
    Applicants: NEC Solution Innovators, Ltd., NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
    Inventors: Hirotaka MINAGAWA, Katsunori HORII, Jou AKITOMI, Naoto KANEKO, Iwao WAGA, Masayasu KUWAHARA
  • Publication number: 20190241895
    Abstract: The present invention provides a novel molecule that can be used for detection of sIgA. The sIgA-binding nucleic acid molecule of the present invention is characterized in that it binds to secretory immunoglobulin A (sIgA) with a dissociation constant of 37.7 nM or less, and preferably includes a polynucleotide consisting of any of base sequences of SEQ ID NOs: 1 to 12 or a partial sequence thereof, for example. According to the sIgA-binding nucleic acid molecule of the present invention, it is possible to detect sIgA in saliva.
    Type: Application
    Filed: April 20, 2017
    Publication date: August 8, 2019
    Applicants: NEC Solution Innovators, Ltd., NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
    Inventors: Hirotaka MINAGAWA, Katsunori HORII, Jou AKITOMI, Naoto KANEKO, Iwao WAGA, Masayasu KUWAHARA
  • Publication number: 20190211048
    Abstract: The present invention provides a novel nucleoside derivative or a salt thereof, a polynucleotide synthesis reagent, a method for producing a polynucleotide, a polynucleotide, and a method for producing a binding nucleic acid molecule. The nucleoside derivative or a salt thereof of the present invention is represented by the following chemical formula (1): where in the chemical formula (1), Su is an atomic group having a sugar skeleton at a nucleoside residue or an atomic group having a sugar phosphate skeleton at a nucleotide residue, and may or may not have a protecting group, L1 and L2 are each independently a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms, X1 and X2 are each independently an imino group (—NR1—), an ether group (—O—), or a thioether group (—S—), and the R1 is a hydrogen atom or a straight-chain or branched, saturated or unsaturated hydrocarbon group having 2 to 10 carbon atoms.
    Type: Application
    Filed: September 14, 2017
    Publication date: July 11, 2019
    Applicants: NEC Solution Innovators, Ltd., NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
    Inventors: Hirotaka MINAGAWA, Katsunori HORII, Jou AKITOMI, Naoto KANEKO, Iwao WAGA, Masayasu KUWAHARA
  • Publication number: 20190120832
    Abstract: A target analysis tool and a target analysis method that allow easily analysis of a target. The first target analysis tool includes: a first chamber; a second chamber; and a third chamber. The first chamber, the second chamber, and the third chamber are disposed continuously in this order. The first chamber contains, as a first reagent, an immobilized first binding substance obtained by immobilizing, on a carrier, a first binding substance that binds to a target. The second chamber contains, as a second reagent, a labeled second binding substance obtained by binding a labeling substance to a second binding substance that binds to the first binding substance. The third chamber is a detection section in which the labeled second binding substance is detected.
    Type: Application
    Filed: December 31, 2018
    Publication date: April 25, 2019
    Applicant: NEC Solution Innovators, Ltd.
    Inventors: Iwao WAGA, Katsunori Horii, Jou Akitomi, Naoto Kaneko, Yoshihito Yoshida